Summary
A 57-year-old male with primary intracranial malignant melanoma who survived 9 years and 6 months is reported.
He underwent surgical removal of the tumour three times during the decade 1978 to 1988, and received chemo-immuno-radiotherapy during that time. Acute tumour growth, suggesting tumour dissemination, was seen in the CT scans after the third removal of recurrent tumour, but then it disappeared after combined chemoradiotherapy with DTIC. He gradually became inactive, probably because of brain atrophy caused by high-dose radiotherapy and chemotherapy, and died of renal failure without any sign of recurrence on CT scans.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arakawa M, Shimizu F, Okada N (1974) Effect of 1-(4-amino-2-methylpyrimidine-5-yl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride on leukemia L-1210. GANN 65: 191
Barranco SC, Romsdahl MM, Humphrey RM (1971) The radiation response of human melanoma cells grown in vitro. Cancer Res 31: 830–833
Bojsen-Moller M (1977) Primary cerebral melanomas—Reports of six cases and a review of the literature. Acta Path Microbiol Scand Sec A 85: 447–454
Cassel WA, Weidenheim KW, Campbell WG Jr, Murray DR (1986) Malignant melanoma-Inflammatory mononuclear cell infiltrates in cerebral metastases during concurrent therapy with viral oncolysate. Cancer 57: 1302–1312
Chiba M, Jimbow K, Kizukuri K, Homma K (1982) Chemoimmunotherapy for disseminated malignant melanoma with DTIC, ACNU, VCR, and OK 432. Case presentation of two complete and partial response out of fifteen attempts. J Dermatol 9: 23–30
Choi KN, Withers HR, Rotman M (1985) Metastatic melanoma in brain. Rapid treatment or large dose fractions. Cancer 56: 10–15
Christensen E (1941) Two cases of primary intracranial melanoma. Acta Chir Scand 85: 90–98
Fischer S (1956) Primary perivascular cerebral, cerebellar and leptomeningeal melanoma (Congenital aphasia and familial predisposition to naevi verrucosi). Acta Psychiatr Kbh 31: 21–34
Gibson JB, Burrows D, Weir WP (1957) Primary melanoma of the meninges. J Pathol Bacteriol 74: 419–438
Grooms GA, Eilber FR, Morton DL (1977) Failure of adjuvant immunotherapy to prevent central nervous system metastases in malignant melanoma patients. J Surg Oncol 9: 147–153
Gutterman JU, McBride C, Freireich EJ, Mavligit G, Frei E III, Hersh EM (1973) Active immunotherapy with BCG for recurrent malignant melanoma. Lancet I: 1208–1212
Habermalz A, Fischer J (1976) Radiation therapy of malignant melanoma-experience with individual treatment doses. Cancer 38: 2258–2262
Hill GJ, Ruess R, Berris R, Philpott GW, Parkin P (1974) Chemotherapy of malignant melanoma with Dimethyl Triazeno Imidazole Carboxamide (DTIC) and Nitrosourea Derivatives (BCNU, CCNU). Ann Surg 180: 167–174
Kaplan AM, Itabashi HH, Hanelin LG (1975) Neuroctaneous melanosis with malignant leptomeningial melanoma. Arch Neurol 32: 669–671
Katz HR (1981) The relative effectiveness of radiation therapy, corticosteroids, and surgery in the management of melanoma metastatic to the central nervous system. Int J Radiat Oncol Biol Phys 7: 897–906
Katz HR (1981) The results of different fractionation schemes in the palliative irradiation of metastatic melanoma. Int J Radiat Oncol Biol Phys 7: 907–911
Kiel FW, Starr LB, Hansen JL (1961) Primary melanoma of the spinal cord. J Neurosurg 18: 616–620
Konefal JB, Emami B, Pilepich MV (1987) Malignant melanoma: analysis of dose fractionation and radiation therapy. Radiology 164: 607–610
Kumagai Y, Sugiyama H, Nawata H, Sugiura M, Kito K, Shitara N (1979) A case of intracranial melanoma who has been survived more than 12 years after initial craniotomy was reported. Brain Nerve 31: 397–402
Morton DL, Eilber FR, Holmes EC, Hunt JS, Ketcham AS, Silverstein MJ, Sparks FC (1974) BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Surgery 180: 635–643
Nikonova OS, Usova MK (1961) Cerebral melanomas. Zh Nevropathol Psikhiatr 58: 526–528
Piscol K, Hoffmann G (1961) Das primÄre Melanoblastome des Zentralnervensystems. Neurochirurgia 4: 1–26
Rawles ME (1948) Origin of melanophores and their role in development of color patterns in vertebrates. Physiol Rev 28: 383–407
Ray BS, Foot NC (1940) Primary melanotic tumors of the meninges: resemblance to meningiomas. Report of two cases in which operation was performed. Arch Neurol Psychiat 44: 104–117
Schnitker MT, Ayer D (1938) The primary melanomas of the leptomeninges. A clinico-pathologic study with a review of the literature and the report of an additional case. J Nerv Ment Dis 87: 45–73
Sinkovics JG, Papadopoulos NE, Plager C (1982) Viraloncolysates for the immunotherapy of human tumors. In: Yohn DS, Blakeslee JR (eds) Advances in comparative leukemia research. Elsevier Biomedical, New York, pp 613–615
Sulis E, Floris C, Chessa A, Desogus A, Muggiano A, Tedde A, Turno R (1987) Sequential treatment with interferon and chemotherapy of metastatic malignant melanoma. Total remission of cutaneous and visceral metastasis, but not of cerebral metastasis. Tumori 73: 55–58
Virchow R (1859) Pigment und diffuse Melanose der Arachnoides. Arch Pathol Anat 16: 180–182
Yamamura Y, Azuma I, Taniyama T, Sugimura K, Hirao F, Tokuzen R, Okabe M, Nakahara W, Yasumoto K, Ohta M (1976) Immunotherapy of cancer with cell wall skeleton of Mycobacterium Bovis-Bacillus Calmette-Guerin: experimental and clinical results. Ann NY Acad Sci 277: 209–227
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakagawa, H., Hayakawa, T., Niiyama, K. et al. Long-term survival after removal of primary intracranial malignant melanoma. Acta neurochir 101, 84–88 (1989). https://doi.org/10.1007/BF01410075
Issue Date:
DOI: https://doi.org/10.1007/BF01410075